# An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

> **NCT07680582** · EARLY_PHASE1 · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** ABO2109 Injection
- **DRUG:** Toripalimab

## Key facts

- **NCT ID:** NCT07680582
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-09
- **Primary completion:** 2028-06-30
- **Final completion:** 2031-02-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-08-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680582, "An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*